Jason Limberis

1.1k total citations
17 papers, 477 citations indexed

About

Jason Limberis is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Jason Limberis has authored 17 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 8 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Jason Limberis's work include Tuberculosis Research and Epidemiology (10 papers), Mycobacterium research and diagnosis (4 papers) and Pneumonia and Respiratory Infections (3 papers). Jason Limberis is often cited by papers focused on Tuberculosis Research and Epidemiology (10 papers), Mycobacterium research and diagnosis (4 papers) and Pneumonia and Respiratory Infections (3 papers). Jason Limberis collaborates with scholars based in United States, South Africa and United Kingdom. Jason Limberis's co-authors include Keertan Dheda, Aliasgar Esmail, Robin M. Warren, Richard Meldau, Grant Theron, Phindile Gina, Greg Calligaro, Lucas Smith, Rouxjeane Venter and Elize Pietersen and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Jason Limberis

16 papers receiving 471 citations

Peers

Countries citing papers authored by Jason Limberis

Since Specialization

Citations

This map shows the geographic impact of Jason Limberis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Limberis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Limberis more than expected).

Fields of papers citing papers by Jason Limberis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Limberis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Limberis. The network helps show where Jason Limberis may publish in the future.

Co-authorship network of co-authors of Jason Limberis

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Limberis. A scholar is included among the top collaborators of Jason Limberis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Limberis. Jason Limberis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Cartridge-based sequencing for bedaquiline resistance detection from sputum 2024 ·SHILAP Revista de lepidopterología ·Jason Limberis, RL Nagel, (unknown), Rebecca E. Colman, (unknown), Zoë Howard, Scott Dewell, Soumitesh Chakravorty, John Metcalfe	0
2	Turbolysis: A low-cost, small footprint alternative to commercial bead beaters for cell lysis 2024 ·HardwareX ·Jason Limberis, John Metcalfe	1
3	Mycobacterium tuberculosis resides in lysosome-poor monocyte-derived lung cells during chronic infection 2024 ·PLoS Pathogens ·Weihao Zheng, (unknown), Jason Limberis, Jonathan M. Budzik, Beth Shoshana Zha, (unknown), (unknown), J. Ernst	15
4	Circularization of rv0678 for Genotypic Bedaquiline Resistance Testing of Mycobacterium tuberculosis 2023 ·Microbiology Spectrum ·Jason Limberis, (unknown), J. Ernst, John Metcalfe	2
5	primerJinn: a tool for rationally designing multiplex PCR primer sets for amplicon sequencing and performing in silico PCR 2023 ·BMC Bioinformatics ·Jason Limberis, John Metcalfe	3
6	Genetic variants and their association with phenotypic resistance to bedaquiline in Mycobacterium tuberculosis: a systematic review and individual isolate data analysis 2021 ·The Lancet Microbe ·Nabila Ismail, (unknown), Jason Limberis, Stella Huo, John Metcalfe, Robin M. Warren, Annelies Van Rie	40
7	Anaerobe-enriched gut microbiota predicts pro-inflammatory responses in pulmonary tuberculosis 2021 ·EBioMedicine ·C Naidoo, (unknown), Imran Sulaiman, Benjamin G. Wu, Carolin T. Turner, (unknown), Zaida Palmer, Yonghua Li, Byron W P Reeve, (unknown), (unknown), Jason Limberis, Andreas H. Diacon, Paul D. van Helden, José C. Clemente, Robin M. Warren, Mahdad Noursadeghi, Leopoldo N. Segal, Grant Theron	35
8	Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis 2020 ·Nature Medicine ·Grant Theron, Jason Limberis, Rouxjeane Venter, Lucas Smith, Elize Pietersen, Aliasgar Esmail, Greg Calligaro, Julian te Riele, (unknown), Paul D. van Helden, Tawanda Gumbo, Taane G. Clark, Kevin P. Fennelly, Robin M. Warren, Keertan Dheda	47
9	A landscape of genomic alterations at the root of a near-untreatable tuberculosis epidemic 2020 ·BMC Medicine ·Marisa Klopper, Tim H. Heupink, Grant Hill-Cawthorne, Elizabeth M. Streicher, Anzaan Dippenaar, Margaretha de Vos, Abdallah M. Abdallah, Jason Limberis, Matthias Merker, (unknown), Stefan Niemann, Keertan Dheda, James E. Posey, Arnab Pain, Robin M. Warren	21
10	Functional α6β4 acetylcholine receptor expression enables pharmacological testing of nicotinic agonists with analgesic properties 2020 ·Journal of Clinical Investigation ·Daniel Knowland, Shenyan Gu, William A. Eckert, (unknown), José A. Matta, Jason Limberis, Alan D. Wickenden, Anindya Bhattacharya, David S. Bredt	12
11	A Human Lung Challenge Model to Evaluate the Safety and Immunogenicity of PPD and Live Bacillus Calmette-Guérin 2019 ·American Journal of Respiratory and Critical Care Medicine ·Malika Davids, Anil Pooran, Clemens Hermann, Lynelle Mottay, (unknown), Jacob Cardenas, (unknown), Thearith Koeuth, Richard Meldau, Jason Limberis, Phindile Gina, Shashikant Srivastava, Bridget Calder, Aliasgar Esmail, Michele Tomasicchio, Jonathan M. Blackburn, Tawanda Gumbo, Keertan Dheda	30
12	A regimen containing bedaquiline and delamanid compared to bedaquiline in patients with drug-resistant tuberculosis 2019 ·European Respiratory Journal ·(unknown), Aliasgar Esmail, Jason Limberis, Keertan Dheda	27
13	Linezolid interruption in patients with fluoroquinolone-resistant tuberculosis receiving a bedaquiline-based treatment regimen 2019 ·International Journal of Infectious Diseases ·(unknown), Aliasgar Esmail, Jason Limberis, Phindile Gina, Keertan Dheda	18
14	Same-Day Tools, Including Xpert Ultra and IRISA-TB, for Rapid Diagnosis of Pleural Tuberculosis: a Prospective Observational Study 2019 ·Journal of Clinical Microbiology ·Richard Meldau, Philippa Randall, Anil Pooran, Jason Limberis, Edson Makambwa, (unknown), Aliasgar Esmail, Keertan Dheda	35
15	Long-term bedaquiline-related treatment outcomes in patients with extensively drug-resistant tuberculosis from South Africa 2018 ·European Respiratory Journal ·(unknown), Jason Limberis, Aliasgar Esmail, Suzette Oelofse, Phindile Gina, Elize Pietersen, Mohammed Fadul, Robin M. Warren, Keertan Dheda	82
16	Xpert MTB/RIF Results in Patients With Previous Tuberculosis: Can We Distinguish True From False Positive Results? 2016 ·Clinical Infectious Diseases ·Grant Theron, Rouxjeane Venter, Greg Calligaro, Lucas Smith, Jason Limberis, Richard Meldau, Duncan Chanda, Aliasgar Esmail, Jonny Peter, Keertan Dheda	101
17	Selected questions and controversies about bedaquiline: a view from the field 2016 ·The International Journal of Tuberculosis and Lung Disease ·Keertan Dheda, Aliasgar Esmail, Jason Limberis, Gary Maartens	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact